Richard L. Leff

2.9k citations

18 papers · 1.7k indexed · 1 hit paper · h-index 15

Co-authors: Paul H. Plötz Frederick W. Miller Lori A. Love Ira N. Targoff Marinos C. Dalakas D. D. Fraser Jeanne E. Hicks David Fraser
Topics: Inflammatory Myopathies and Dermatomyositis (8 papers)Osteoarthritis Treatment and Mechanisms (4 papers)Inflammatory mediators and NSAID effects (3 papers)
Cited by: Rheumatology Epidemiology Dermatology
Journals: The Lancet Journal of Biological Chemistry Annals of the New York Academy of Sciences
Partner nations: United States United Kingdom Israel

In The Last Decade

Richard L. Leff

18 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A New Approach to the Classification of Idiopathic Inflammatory Myopathy

1991 694 citations Lori A. Love, Richard L. Leff et al. Medicine profile →

Peers

Countries citing papers authored by Richard L. Leff

Since Specialization

Citations

This map shows the geographic impact of Richard L. Leff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard L. Leff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard L. Leff more than expected).

Fields of papers citing papers by Richard L. Leff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard L. Leff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard L. Leff. The network helps show where Richard L. Leff may publish in the future.

Co-authorship network of co-authors of Richard L. Leff

This figure shows the co-authorship network connecting the top 25 collaborators of Richard L. Leff. A scholar is included among the top collaborators of Richard L. Leff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard L. Leff. Richard L. Leff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	NEO6860, modality-selective TRPV1 antagonist: a randomized, controlled, proof-of-concept trial in patients with osteoarthritis knee pain 2018 ·PAIN Reports ·Pierre Arsenault,D. Chiche,W. A. Brown,Jeffrey Miller,Roi Treister,Richard L. Leff,Philippe Walker,Nathaniel P. Katz	48
2	Safety, Pharmacokinetics, and Pharmacodynamics Study in Healthy Subjects of Oral NEO6860, a Modality Selective Transient Receptor Potential Vanilloid Subtype 1 Antagonist 2017 ·Journal of Pain ·W. A. Brown,Richard L. Leff,Andrew M. Griffin,Stuart Hossack,(unknown),Philippe Walker,D. Chiche	42
3	Demographic and clinical features of inclusion body myositis in north America 2014 ·Muscle & Nerve ·A. David Paltiel,Einar T. Ingvarsson,Donald Lee,Richard L. Leff,Richard J. Nowak,(unknown),Seth Richards‐Shubik,(unknown),Martín Shubik,Kevin C. O’Connor	25
4	Safety issues in the development of treatments for osteoarthritis: recommendations of the Safety Considerations Working Group 2011 ·Osteoarthritis and Cartilage ·Vibeke Strand,D. Blöch,Richard L. Leff,Paul M. Peloso,Lee S. Simon	2
5	Classification of rheumatoid arthritis status with candidate gene and genome-wide single-nucleotide polymorphisms using random forests 2007 ·BMC Proceedings ·Yan V. Sun,Zhaohui Cai,(unknown),(unknown),Richard L. Leff,(unknown),Sharon L. R. Kardia,Huiying Yang	25
6	Reproducibility of the semiflexed (metatarsophalangeal) radiographic knee position and automated measurements of medial tibiofemoral joint space width in a multicenter clinical trial of knee osteoarthritis. 2004 ·PubMed ·J. C. Buckland‐Wright,R.J. Ward,Charles Peterfy,Christopher F. Mojcik,Richard L. Leff	60
7	Molecular changes in human osteoarthritic cartilage after 3 weeks of oral administration of BAY 12-9566, a matrix metalloproteinase inhibitor. 2003 ·PubMed ·Richard L. Leff,Ileana Elias,Mirela Ionescu,A Reiner,A. Robin Poole	24
8	Clinical Trials of a Stromelysin Inhibitor: Osteoarthritis, Matrix Metalloproteinase Inhibition, Cartilage Loss, Surrogate Markers, and Clinical Implications 1999 ·Annals of the New York Academy of Sciences ·Richard L. Leff	26
9	Treatment of refractory myositis: A randomized crossover study of two new cytotoxic regimens 1998 ·Arthritis & Rheumatism ·(unknown),(unknown),Elizabeth M. Adams,Jeffrey B. Sherman,(unknown),Richard L. Leff,(unknown),(unknown),Paul H. Plötz,Frederick W. Miller	120
10	Treatment of refractory myositis: A randomized crossover study of two new cytotoxic regimens 1998 ·Arthritis & Rheumatism ·(unknown),Jeanne E. Hicks,Elizabeth M. Adams,Jeffrey B. Sherman,Mark F. Gourley,Richard L. Leff,(unknown),(unknown),Paul H. Plötz,Frederick W. Miller	101
11	Office evaluation and treatment of Raynaud's phenomenon 1995 ·Cleveland Clinic Journal of Medicine ·Marcy B. Bolster,H R Maricq,Richard L. Leff	6
12	A motif in human histidyl-tRNA synthetase which is shared among several aminoacyl-tRNA synthetases is a coiled-coil that is essential for enzymatic activity and contains the major autoantigenic epitope. 1994 ·Journal of Biological Chemistry ·Nina Raben,(unknown),J.G. Dohlman,P McPhie,Vandana Sridhar,(unknown),Richard L. Leff,P H Plotz	72
13	The Treatment of Inclusion Body Myositis 1993 ·Medicine ·Richard L. Leff,Frederick W. Miller,Jeanne E. Hicks,David Fraser,Paul H. Plötz	90
14	Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy 1993 ·The American Journal of Medicine ·Marshall M. Joffe,Lori A. Love,Richard L. Leff,David Fraser,Ira N. Targoff,Jeanne E. Hicks,Paul H. Plötz,Frederick W. Miller	211
15	Viruses in idiopathic inflammatory myopathies: absence of candidate viral genomes in muscle 1992 ·The Lancet ·Richard L. Leff,L. A. Love,Frederick W. Miller,Paul H. Plötz,Steven J. Greenberg,Edmund Klein,M. C. Dalakas	92
16	A New Approach to the Classification of Idiopathic Inflammatory Myopathybreakdown → 1991 ·Medicine ·Lori A. Love,Richard L. Leff,D. D. Fraser,Ira N. Targoff,Marinos C. Dalakas,Paul H. Plötz,Frederick W. Miller	694
17	Distinct seasonal patterns in the onset of adult idiopathic inflammatory myopathy in patients with anti‐jo‐1 and anti‐signal recognition particle autoantibodies 1991 ·Arthritis & Rheumatism ·Richard L. Leff,(unknown),Frederick W. Miller,Lori A. Love,Ira N. Targoff,Marinos C. Dalakas,Marshall M. Joffe,Paul H. Plötz	87
18	A possible role for oxygen inactivation in the regulation of amidophosphoribosyltransferase activity in mammalian cells 1984 ·Advances in Enzyme Regulation ·Richard L. Leff,Mitsuo Itakura,(unknown),Edward W. Holmes	9

About Richard L. Leff

Richard L. Leff is a scholar working on Rheumatology, Sensory Systems and Dermatology, having authored 18 papers that have together received 1.7k indexed citations. Recurring topics across this work include Inflammatory Myopathies and Dermatomyositis (8 papers), Osteoarthritis Treatment and Mechanisms (4 papers) and Inflammatory mediators and NSAID effects (3 papers). The work is most often cited by research in Rheumatology (826 citations), Epidemiology (1.4k citations) and Dermatology (244 citations). Richard L. Leff has collaborated with scholars based in United States, United Kingdom and Israel. Frequent co-authors include Paul H. Plötz, Frederick W. Miller, Lori A. Love, Ira N. Targoff, Marinos C. Dalakas, D. D. Fraser, Jeanne E. Hicks, David Fraser, Marshall M. Joffe and Elizabeth M. Adams. Their work appears in journals such as The Lancet, Journal of Biological Chemistry and Annals of the New York Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact